Strategies for General Practitioners to Enhance Cancer Care: Insights from a Patient-Centered Questionnaire Survey in Southern China
DOI: https://doi.org/10.2147/jmdh.s460881
2024-06-12
Journal of Multidisciplinary Healthcare
Abstract:Wenxia Wu, 1, 2, &ast Jingwei Tian, 1, &ast Lisha Xiao, 1 Haochen Mai, 1 Phei Er Saw, 3– 5 Meng Zhang 1, 2 1 Department of General Practice, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China; 2 Department of General Practice, Shenshan Medical Center, Sun Yat-sen Memorial Hospital, Shanwei, Guangdong, People's Republic of China; 3 Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China; 4 Guangzhou Key Laboratory of Medical Nanomaterials, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China; 5 Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-Sen Memorial Hospital, Foshan, Guangdong, People's Republic of China &astThese authors contributed equally to this work Correspondence: Phei Er Saw; Meng Zhang, Email ; Background: The incidence of cancer is increasing, and cancer survivors are also growing exponentially. Cancer is defined as a new chronic disease. Nevertheless, the management of cancer in the form of chronic diseases in China is still in its infancy, without a standardized care model. Objective: This study aimed to explore the current status of management of cancer care from the patient's perspective. Methods: This cross-sectional study was a questionnaire survey of patients diagnosed with cancer, including information of the current situation of daily medical consultation, status of comorbidity, and expectations of seeking cancer care in future. Chi-square test and logistic regression analysis were used to explore the factors influencing patients' choice of cancer management mode. Results: A total of 200 cancer patients were included in the study. The majority (n = 150) of cancer patients chose an oncologist in a tertiary hospital for cancer care. Difficulty in registration (45%), time-consuming (34.5%), repeated examinations (34.5%) and different treatment opinions (12.0%) were the main difficulties they encountered currently during tertiary hospital visits. In community hospital, lack of trust in general practitioners (n = 33) and the necessary drugs or testing items in community hospitals (n = 47) were the main difficulties during their visits. Logistic regression analysis showed that male (OR = 2.737, 95% CI, 1.332– 5.627, p = 0.006) and elderly patients (OR = 3.186, 95% CI, 1.172– 8.661, p = 0.023) were more likely to choose general practitioners (GPs) in community hospitals. Twenty-nine (14.5%) patients hope to have an integrated multidisciplinary management in tertiary and community hospitals with the active participation of GPs for cancer care. Conclusion: Improving drug availability, equipment and quality of cancer care services can help to increase cancer patients' recognition of community hospital. In addition, the multidisciplinary management integrated tertiary hospitals and communities with the participation of GPs is a worth exploring mode that improves the management of cancer care. Keywords: cancer care, chronic disease management, general practitioners, GPs, multidisciplinary In recent years, the incidence of cancer has significantly increased globally. In developed countries, for example, approximately half of all North Americans will be diagnosed with cancer at some point of their lifetimes. 1 This situation is even more severe in China. According to the Cancer Statistics 2023, cancer incidence and mortality rates of China rank first in the world. In China, there were 4.57 million newly diagnosed cancer patients, accounting for 23.7% of the world's total, and 3 million cancer deaths, accounting for 30% of cancer deaths in 2020. 2 These have become an important public health problem for China. World Health Organization (WHO) has categorized cancer as a chronic disease, and the management of cancer is now a slow and progressive. 3 Cancer survivor is defined as an individual who has completed curative-intent therapy, need ongoing care on surveillance, prevention of adverse treatment-related effects and maintenance treatments. 4 In recent years, patients living with incurable cancer and living for years with chronic treatments were considered to the new survivor population. From this perspective, cancer has the characteristics of chronic diseases, that are developed slowly, last a long time (from months to years), be incurable, and be progressive and/or life-limiting. 5 Owing to -Abstract Truncated-
health care sciences & services